DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global supplier of healthcare products, today provided an update on its operations in Japan. The Company confirmed that all of its nearly 1,500 employees in Japan are safe and that its office in Tokyo is undamaged and functional. Covidien's manufacturing facility in Shizuoka and its distribution centers in Shizuoka and Tokyo did not suffer any damage.
